Literature DB >> 32209516

Malignant Otitis Externa: Causes for Various Treatment Responses.

Nenad Arsovic1, Nemanja Radivojevic1, Snezana Jesic1, Snezana Babac2, Ljiljana Cvorovic1, Zoran Dudvarski1.   

Abstract

OBJECTIVES: Malignant (necrotizing) otitis externa (MOE) is an aggressive form of skin inflammation of the external ear with a tendency to spread infection to the temporal bone. The study aimed to evaluate a causal relationship between treatment responses and clinical features in patients with MOE.
MATERIALS AND METHODS: In a retrospective, descriptive section study, the database was analyzed between January 2008 and December 2018 in our department, all patients with diagnosed MOE were identified.
RESULTS: A total of 30 patients were evaluated, of which 27 men and 3 women. The youngest patient was 52 years old while he was eldest 88 years, (mean-71 years old). As the most common comorbidity, diabetes mellitus was found in 23 (76%) subjects. Median duration of symptoms was about 3 months. The most common isolated pathogen was Pseudomonas aeruginosa (47%). Patients with facial nerve palsy and erosion of temporal bone find on computerized tomography affect prolonged stationary treatment (Mean, SD 29.2±8.5 and 26,7±11.6 days), while 80% of patients with facial nerve palsy had recurrence of disease (p=0.005) with mean duration of clinical remission of 60±17.3 days. Overall length of treatment is also increased in the presence of comorbidities as well as in patients with cranial nerve involvement.
CONCLUSION: Patients with cranial nerve involvement, erosion of temporal bone and presence of comorbidities affect prolonged treatment and adverse prognosis. Early diagnosis and initiation of aggressive therapy are essential for stopping the further spread of the disease and prevention of serious complications.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32209516      PMCID: PMC7224427          DOI: 10.5152/iao.2020.7709

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  27 in total

1.  Optimal Duration of Antibiotic Therapy in Patients With Hematogenous Vertebral Osteomyelitis at Low Risk and High Risk of Recurrence.

Authors:  Ki-Ho Park; Oh-Hyun Cho; Jung Hee Lee; Ji Seon Park; Kyung Nam Ryu; Seong Yeon Park; Yu-Mi Lee; Yong Pil Chong; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; In-Gyu Bae; Yang Soo Kim; Jun Hee Woo; Mi Suk Lee
Journal:  Clin Infect Dis       Date:  2016-02-24       Impact factor: 9.079

Review 2.  The diagnostic criteria of malignant external otitis.

Authors:  D Cohen; P Friedman
Journal:  J Laryngol Otol       Date:  1987-03       Impact factor: 1.469

3.  Current management of necrotising otitis externa in the UK: survey of 221 UK otolaryngologists.

Authors:  Gaurav Chawdhary; Miran Pankhania; Susan Douglas; Ian Bottrill
Journal:  Acta Otolaryngol       Date:  2017-03-16       Impact factor: 1.494

4.  Malignant otitis externa, an increasing burden in the twenty-first century: review of cases in a UK teaching hospital, with a proposed algorithm for diagnosis and management.

Authors:  K H Hutson; G J Watson
Journal:  J Laryngol Otol       Date:  2019-04-12       Impact factor: 1.469

5.  Prognostic value of extension patterns on follow-up magnetic resonance imaging in patients with necrotizing otitis externa.

Authors:  Ji-Eun Lee; Jae-Jin Song; Seung-Ha Oh; Sun O Chang; Chang-Hee Kim; Jun Ho Lee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-07

Review 6.  Necrotizing otitis externa: a systematic review.

Authors:  Pouya Mahdyoun; Céline Pulcini; Ivan Gahide; Charles Raffaelli; Charles Savoldelli; Laurent Castillo; Nicolas Guevara
Journal:  Otol Neurotol       Date:  2013-06       Impact factor: 2.311

7.  Malignant Otitis Externa - A Retrospective Study of 15 Patients Treated in a Tertiary Healthcare Center.

Authors:  Vadisha Bhat; Ajaz Aziz; Satheesh Kumar Bhandary; Rajeshwary Aroor; Shrinath D Kamath P; Marina Saldanha
Journal:  J Int Adv Otol       Date:  2015-04       Impact factor: 1.017

8.  Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors.

Authors:  Shaun Loh; Woei Shyang Loh
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04-04       Impact factor: 3.497

9.  Malignant Otitis Externa Outcomes: A Study of the University HealthSystem Consortium Database.

Authors:  Jonathan L Hatch; Michael J Bauschard; Shaun A Nguyen; Paul R Lambert; Ted A Meyer; Theodore R McRackan
Journal:  Ann Otol Rhinol Laryngol       Date:  2018-07-02       Impact factor: 1.547

10.  Malignant Otitis Externa: A Retrospective Analysis and Treatment Outcomes.

Authors:  İsa Kaya; Baha Sezgin; Sevinç Eraslan; Kerem Öztürk; Sercan Göde; Cem Bilgen; Tayfun Kirazlı
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01
View more
  4 in total

1.  Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.

Authors:  Oyewole Chris Durojaiye; Augustinas Slucka; Evangelos I Kritsotakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-13       Impact factor: 3.267

2.  Malignant Otitis Externa: How to Monitor the Disease in Outcome Estimation?

Authors:  Ayse Pelin Yigider; Okan Ovunc; Esra Arslan; Ahmet Volkan Sunter; Tevfik Fikret Cermik; Ozgur Yigit
Journal:  Medeni Med J       Date:  2021-03-26

3.  A Comparison of Antifungal Drugs and Traditional Antiseptic Medication for Otomycosis Treatment: A Systematic Review and Meta-Analysis.

Authors:  Shunyu Wu; Yin Cheng; Shunzhang Lin; Huanhai Liu
Journal:  Front Surg       Date:  2021-12-22

Review 4.  What Is New in the Anti-Pseudomonas aeruginosa Clinical Development Pipeline Since the 2017 WHO Alert?

Authors:  Sébastien Reig; Audrey Le Gouellec; Sophie Bleves
Journal:  Front Cell Infect Microbiol       Date:  2022-07-08       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.